📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide. (2013)

First Author: Henry JY

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/imm.12087

PubMed Identifier: 23374145

Publication URI: http://europepmc.org/abstract/MED/23374145

Type: Journal Article/Review

Volume: 139

Parent Publication: Immunology

Issue: 3

ISSN: 0019-2805